Concepedia

Rohit Talwani

RT

Statistics

Publications

25

Citations

1.5K

H-Index

18

Active since

2002

Affiliations

University of Maryland, Baltimore(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Institutes of Health

Pusan National University Hospital

Gilead Sciences (United States)

Rohit Talwani is an author at University of Maryland, Baltimore specializing in medicine, viral hepatitis, and hepatitis.

ORCID

Top concepts

Publications per year

2002–2019

25

Publications

25

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

A. Osinusi, Eric G. Meissner, Y.-J. Lee et al. · JAMA · 2013 · 285 citations · Full text

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of <i>Staphylococcus aureus</i> Bacteremia

J. John Weems, James P. Steinberg, Scott G. Filler et al. · Antimicrobial Agents and Chemotherapy · 2006 · 153 citations · Full text

, , +22

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +9

Diagnosis and management of Lyme disease.

William F. Wright, David J. Riedel, Rohit Talwani et al. · PubMed · 2012 · 76 citations

, , +14

1–5 of 25